Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda, on the topic of “Remote Monitoring of Speech and Voice as Clinical Markers of Health” at the Digital Health and AI Innovation Summit in Boston, MA, from October 7 – 9, 2024.

Why Attend?

• Connect with over 400 industry leaders from pharma, medtech, academia, and healthcare.
• Stay updated on the latest trends in clinical innovation and digital transformation.
• Network with professionals dedicated to advancing patient care through AI.

Key topics will include AI’s impact on patient-doctor interactions, precision medicine, FDA oversight, and more.

For more information about the conference, please visit the website.